Generation of human induced pluripotent stem cell lines (iPSC) from adipose-derived mesenchymal stromal cells from two patients with systemic sclerosis

被引:0
|
作者
Velier, Melanie [1 ,2 ]
Appay, Romain [3 ,4 ]
Arcani, Robin [1 ,5 ,6 ]
Desprat, Romain [7 ]
Simoncini, Stephanie [1 ]
Zavarro, Anouck [1 ]
Noel, Daniele [8 ]
Bendaass, Lenha [1 ]
Jorgensen, Christian [7 ,8 ,10 ]
De Pinho, Quentin Gomes [1 ,9 ]
Benyamine, Audrey [1 ,9 ]
Granel, Brigitte [1 ,9 ]
Daumas, Aurelie [1 ,5 ,6 ]
George, Francoise Dignat [1 ]
Sabatier, Florence [1 ,2 ]
Magalon, Jeremy [1 ,2 ]
机构
[1] Aix Marseille Univ, INSERM 1263, INRAE1260, C2VN, Marseille, France
[2] Hop Conception, AP HM, INSERM, CIC BT 1409,Culture & Cell Therapy Lab, Marseille, France
[3] Hop La Timone, AP HM, Dept Pathol Anat & Neuropathol, Marseille, France
[4] Aix Marseille Univ, CNRS, Inst Neurophysiopathol, Marseille, France
[5] Hop La Timone, AP HM, Dept Internal Med, Marseille, France
[6] Hop La Timone, AP HM, Therapeut Dept, Marseille, France
[7] CHU Montpellier, Plateforme SAFE iPS, IRMB, Montpellier, France
[8] Univ Montpellier, INSERM, IRMB, Montpellier, France
[9] Hop Nord Marseille, AP HM, Internal Med Dept, Marseille, France
[10] CHU Montpellier, Clin Immunol & Osteoarticular Dis Therapeut Unit, Dept Rheumatol, Montpellier, France
关键词
D O I
10.1016/j.scr.2024.103624
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Systemic sclerosis (SSc) is a rare and complex connective tissue disease associated with high morbidity and mortality. SSc is characterized by ischemic vasculopathy, cutaneous and visceral fibrosis and a dysimmune state (Denton and Khanna, 2017; Volkmann et al., 2023; Barnes and Mayes, 2012). We have derived induced pluripotent stem cell (iPSC) lines from two SSc patients aged 38 and 67 years with severe vascular phenotype. These iPSC lines expressed pluripotent markers, exhibited normal and stable genome, and differentiated into trilineage embryonic layers in teratoma formation assays. These SSc-specific iPSC lines can be differentiated into endothelial cells, providing a valuable model to elucidate vascular dysfunction and develop personalized therapeutic approaches.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Generation of Human Induced Pluripotent Stem Cell Lines from Patients with Hand Osteoarthritis
    Castro-Vinuelasi, Rocio
    Sanjurjo-Rodriguez, Clara
    Pineiro-Ramil, Maria
    Hermida-Gomez, Tamara
    De Toro Santos, Francisco Javier
    Blanco, Francisco J.
    Fuentes-Boquete, Isaac
    Maria Diaz-Prado, Silvia
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] Establishment of a collection of human pluripotent stem cell lines (iPSC) from mesenchymal stem cells (MSC) from three healthy elderly donors
    Pichard, Lydiane
    Brondello, Jean-Marc
    Becker, Fabienne
    Desprat, Romain
    De Ceuninck, Frederic
    Pastoureau, Philippe
    Noel, Daniele
    Jorgensen, Christianf
    Lemaitre, Jean-Marc
    STEM CELL RESEARCH, 2021, 53
  • [43] Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model
    Soontararak, Sirikul
    Chow, Lyndah
    Johnson, Valerie
    Coy, Jonathan
    Wheat, William
    Regan, Daniel
    Dow, Steven
    STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (06) : 456 - 467
  • [44] Pluripotent stem cell lines derived from human somatic cells
    Roitberg, Ben
    SURGICAL NEUROLOGY, 2008, 69 (03): : 224 - 225
  • [45] Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion
    Arai, Yutaka
    Takami, Miho
    An, Yuri
    Matsuo-Takasaki, Mami
    Hemmi, Yasuko
    Wakabayashi, Tamami
    Inoue, Jun
    Noguchi, Michiya
    Nakamura, Yukio
    Sugimoto, Keisuke
    Takemura, Tsukasa
    Okita, Keisuke
    Osafune, Kenji
    Takasato, Minoru
    Hayata, Tadayoshi
    Hayashi, Yohei
    STEM CELL RESEARCH, 2020, 45
  • [46] GENERATION OF TWO HUMAN INDUCED PLURIPOTENT STEM CELL LINES DERIVED FROM TWO JUVENILE NEPHRONOPHTHISIS PATIENTS WITH NPHP1 DELETION
    Arai, Yutaka
    Luijkx, Dorian
    Takasaki, Mami Matsuo
    Hemmi, Yasuko
    Wakabayashi, Tamami
    Inoue, Jun
    Noguchi, Michiya
    Nakamura, Yukio
    Sugimoto, Keisuke
    Takemura, Tsukasa
    Okita, Keisuke
    Osafune, Kenji
    Takasato, Minoru
    Hayata, Tadayoshi
    Hayashi, Yohei
    TISSUE ENGINEERING PART A, 2022, 28 : S104 - S105
  • [47] Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells
    Xu, Maojia
    Shaw, Georgina
    Murphy, Mary
    Barry, Frank
    STEM CELLS, 2019, 37 (06) : 754 - 765
  • [48] CHARACTERIZATION OF THE STROMAL VASCULAR FRACTION AND OF THE ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS ISOLATED FROM THE TWO COMPARTMENTS OF THE SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE IN HUMAN
    Laloze, J.
    Chaput, B.
    Prevost, A.
    Casteilla, L.
    Desmouliere, A.
    Varin, A.
    CYTOTHERAPY, 2021, 23 (05) : S60 - S60
  • [49] Comparison of trophic factors secreted from human adipose-derived stromal vascular fraction with those from adipose-derived stromal/stem cells in the same individuals
    Hirose, Yujiro
    Funahashi, Yasuhito
    Matsukawa, Yoshihisa
    Majima, Tsuyoshi
    Yamaguchi, Masaya
    Kawabata, Shigetada
    Gotoh, Momokazu
    Yamamoto, Tokunori
    CYTOTHERAPY, 2018, 20 (04) : 589 - 591
  • [50] Generation and characterization of a functional human adipose-derived multipotent mesenchymal stromal cell line
    Burk, Janina
    Holland, Heidrun
    Lauermann, Anne F.
    May, Tobias
    Siedlaczek, Philipp
    Charwat, Verena
    Kasper, Cornelia
    BIOTECHNOLOGY AND BIOENGINEERING, 2019, 116 (06) : 1417 - 1426